Sharp Decline Seen in Use of Cardiac Nuclear Myocardial Perfusion Imaging
By MedImaging International staff writers Posted on 15 Apr 2014 |
There has been a substantial decrease in the use of nuclear myocardial perfusion imaging (MPI) since 2006, an imaging modality used to detect areas of the heart with decreased blood flow, a decline that cannot be justified by an increase in other imaging methods, according to recent findings.
The new findings were published March 26, 2014, in the Journal of the American Medical Association (JAMA). Nuclear MPI accounted for much of the rapid growth in cardiac imaging that occurred from the 1990s through the middle 2000s. Edward J. McNulty, MD, from Kaiser Permanente Medical Center (San Francisco, CA, USA) and colleagues conducted a study to examine trends in MPI use within a large, community-based population. They gathered patient data for MPI performed from 2000–2011 for members ages 30 years or older from the clinical databases of Kaiser Permanente Northern California, an integrated healthcare delivery system that provides inpatient and outpatient care for more than 2.3 million adults.
Overall, MPI was used to treat 302,506 patients at 19 facilities. MPI use from 2000 until 2006 increased by a comparative 41%, but between 2006 and 2011, MPI use declined a relative 5%. Declines from 2006 to 2011 were greater for outpatients than inpatients (58% vs. 31%) and for persons younger than 65 years. Use of cardiac computed tomography (CT), a newer imaging technology, increased during this time period, and could have accounted for 5% of the observed decline in overall MPI use if performed as an option.
“Although the abrupt nature of the decline suggests changing physician behavior played a major role, incident coronary disease, as assessed by [heart attack], also declined [by 27%]. We could not determine the relative effects of these factors on MPI use,” the authors wrote. “...the substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in healthcare costs.”
Related Links:
Kaiser Permanente Medical Center
The new findings were published March 26, 2014, in the Journal of the American Medical Association (JAMA). Nuclear MPI accounted for much of the rapid growth in cardiac imaging that occurred from the 1990s through the middle 2000s. Edward J. McNulty, MD, from Kaiser Permanente Medical Center (San Francisco, CA, USA) and colleagues conducted a study to examine trends in MPI use within a large, community-based population. They gathered patient data for MPI performed from 2000–2011 for members ages 30 years or older from the clinical databases of Kaiser Permanente Northern California, an integrated healthcare delivery system that provides inpatient and outpatient care for more than 2.3 million adults.
Overall, MPI was used to treat 302,506 patients at 19 facilities. MPI use from 2000 until 2006 increased by a comparative 41%, but between 2006 and 2011, MPI use declined a relative 5%. Declines from 2006 to 2011 were greater for outpatients than inpatients (58% vs. 31%) and for persons younger than 65 years. Use of cardiac computed tomography (CT), a newer imaging technology, increased during this time period, and could have accounted for 5% of the observed decline in overall MPI use if performed as an option.
“Although the abrupt nature of the decline suggests changing physician behavior played a major role, incident coronary disease, as assessed by [heart attack], also declined [by 27%]. We could not determine the relative effects of these factors on MPI use,” the authors wrote. “...the substantial reduction in MPI use demonstrates the ability to reduce testing on a large scale with anticipated reductions in healthcare costs.”
Related Links:
Kaiser Permanente Medical Center
Latest Nuclear Medicine News
- New PET Agent Rapidly and Accurately Visualizes Lesions in Clear Cell Renal Cell Carcinoma Patients
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure